APPlife Finalizes 20M-to-990M Authorized Share Increase, Effective No Earlier Than Nov 19
ALDS has more than doubled off its 52-week low of $0.012.
Summary
APPlife's definitive information statement confirms stockholders already approved raising authorized common stock from 20 million to 990 million shares, effective no earlier than November 19, 2026. The company was already 6.1 million shares short of its contractual reservation obligations, and October note conversions at $0.05-$0.052 may trigger further anti-dilution.
Key Events · Financing and Capital Events · ALDS
-
Authorized Shares Raised to 990 Million
Stockholders holding 77.56% of voting power consented on October 19, 2026 to increase authorized common stock from 20,000,000 to 990,000,000 shares; the amendment cannot take effect before November 19, 2026.
-
Reservation Shortfall Drives the Increase
8,212,128 shares outstanding plus 17,911,912 reserved total 26,124,040 against 20,000,000 authorized — a 6,124,040-share shortfall that puts the company out of compliance with Series D and note reservation covenants.
-
Dilution Potential Is Extreme
The 990,000,000 authorized shares equal about 120.6 times the 8,212,128 shares outstanding (990,000,000 / 8,212,128), and the board can issue them without further stockholder approval.
-
October Conversions May Trigger Ratchets
Conversions at $0.05-$0.052 (ClearThink 400,000 shares, Labrys 163,800 shares, Bionance 410,000 shares) are below the Series D conversion price; a reset to $0.05 would make the 810 Series D shares convertible into about 16,200,000 shares and require roughly 24,300,000 reserved.
Analysis · ALDS · Trade & Services
The 990 million authorized share count is roughly 120.6 times the 8.2 million shares outstanding, and the company already has 17.9 million shares reserved against only 20 million authorized — a 6.1 million share shortfall. That shortfall is why this is not routine housekeeping: the Series D certificate requires 150% reservation and mandates an authorized increase if the company cannot comply, so the amendment is the mechanism that keeps convertible holders from triggering defaults or cash settlement demands. Against a going-concern warning and $21,725 of cash versus $4.1 million in current liabilities, the new headroom will almost certainly be used to convert notes and settle obligations in stock rather than to raise equity at a good price. The October conversions at $0.05-$0.052 are below the Series D conversion price, which the company says may trigger full-ratchet anti-dilution — if Series D resets to $0.05, those 810 shares alone become about 16.2 million shares and require roughly 24.3 million reserved. Existing holders should expect heavy dilution; the Series C holders, including the CEO/CFO vehicle and Christopher Davenport, are insulated because each Series C share converts to a fixed 0.01% of fully diluted stock plus 25% of all other votes.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALDS was trading at $0.04 on OTC in the Trade & Services sector, with a market capitalization of approximately $328.5K. The 52-week trading range was $0.01 to $8.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.